Latest Security News

Jade Gas Holdings has achieved continuous gas flow from two production wells and secured its first LNG sales agreement with Mongolia’s largest natural gas importer, UB Metan LLC. The company also raised $5 million to support its commercial operations.

Micro-X Ltd has secured its largest-ever $3.3 million Rover Plus order from Malaysia’s Ministry of Health and is progressing critical Head CT imaging trials, supported by a $4.4 million government grant.

PhosCo Ltd reports breakthrough drilling results at its Gasaat Phosphate Project in Tunisia, securing a €1M grant from EBRD and a $1.1M investment from its Managing Director, setting the stage for a pivotal feasibility study.

ABx Group Limited reports strong progress in rare earth extraction and clean chemical production, backed by strategic investments and a recent $3 million capital raise.

Victory Metals has significantly upgraded its North Stanmore rare earths resource, reporting record dysprosium grades and producing a high-purity rare earth oxide. The company also secured strategic partnerships and $11.5 million in new funding.

Elevate Uranium has raised $25 million through a well-supported placement, boosting its cash reserves to nearly $44 million. The funds will accelerate its proprietary U-pgrade™ pilot plant and expand uranium resource drilling in Namibia and Australia.

Po Valley Energy reported consistent gas production and strong cash flow in Q3 2025, while advancing development plans and a new gas sales agreement in Italy.

TG Metals Limited reports strong progress in its September quarter with successful stockpile metallurgy, high-grade laterite discovery at Van Uden, and expanded soil geochemistry targets at both Van Uden and Gold City projects.

Artrya Limited has completed the second tranche of its share placement, raising $14.7 million to advance its AI-powered Salix platform for coronary artery disease detection.

Golden Horse Minerals has raised A$35 million through a strongly supported placement to accelerate exploration and development at its Southern Cross Gold Project in Western Australia.

Central Petroleum reported a slight dip in sales volumes and revenue for the September quarter, offset by a significant reserves upgrade and a new long-term gas supply agreement that promises cash flow stability.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.